Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00577538 · ClinicalTrials.gov registry record
Prevalence of Lymphoma in IBD
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 7
- Enrollment target
NCT00577538: Completed study, sponsored by Indiana University.
NCT00577538 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00577538 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
Patients with inflammatory bowel disease (IBD) may be at increased risk of lymphoma. The majority of lymphomas in patients with IBD occur in areas of active inflammation. The relationship between IBD and lymphoproliferative disease is however unclear, since both chronic inflammation as well as medications used to treat IBD (especially immunosuppressives - Azathioprine or 6-MP - and anti-TNF alpha agents) have been associated with increased risk of lymphoma. We plan to study the association between IBD and lymphoma in a large, mixed, community based and referral population from the IBD database at Indiana University.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2006-04 |
| Est. Completion | 2008-10 |
What the finished NCT00577538 record still lists
NCT00577538 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00577538 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00577538 about?
NCT00577538 is a clinical study titled "Prevalence of Lymphoma in IBD". Patients with inflammatory bowel disease (IBD) may be at increased risk of lymphoma. The majority of lymphomas in patients with IBD occur in areas of active inflammation. The relationship between IBD and lymphoproliferative disease is however unclear, since both chronic inflammation as well as medic...
What is the current status of trial NCT00577538?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2006-04. Estimated completion is 2008-10.
Who is sponsoring clinical trial NCT00577538?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia